Literature DB >> 1809161

Variations in the carcinogenicity of tremolite dust samples of differing morphology.

J M Davis1, J Addison, C McIntosh, B G Miller, K Niven.   

Abstract

Six samples of tremolite of different morphological type were prepared as dusts of respirable size and used in intraperitoneal injection studies in rats. Three "asbestiform" tremolites produced mesotheliomas in almost all animals, although with significantly different tumor-induction periods. A brittle type of fibrous tremolite which, when manipulated to prepare "respirable dust," produced a sample with relatively few asbestiform fibers remaining nonetheless produced tumors in 70% of rats. Two samples of nonfibrous tremolite produced respirable dust samples containing numerous elongated fragments with aspect ratios greater than 3:1, which therefore fitted the definition of respirable fibers. Both these samples produced relatively few tumors, although one had more long "fibers" than did the brittle tremolite that produced 70% of tumors. This study has therefore demonstrated that different morphologic forms of tremolite produce dusts with very different carcinogenic potential. Carcinogenicity does not depend simply on the number of elongated particles injected, and we need to develop methods of distinguishing carcinogenic tremolite fibers from relatively innocuous tremolite dusts, with similar numbers of elongated particles of similar aspect ratios.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1809161     DOI: 10.1111/j.1749-6632.1991.tb24497.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  9 in total

Review 1.  State-of-the-science assessment of non-asbestos amphibole exposure: is there a cancer risk?

Authors:  Cris Williams; Linda Dell; Robert Adams; Tracie Rose; Drew Van Orden
Journal:  Environ Geochem Health       Date:  2012-12-12       Impact factor: 4.609

2.  A commentary on Roggli's "The So-Called Short-Fiber Controversy".

Authors:  David Egilman; Triet Tran
Journal:  Int J Occup Environ Health       Date:  2016-05-24

3.  Exposure to tremolite asbestos and respiratory health in Swedish dolomite workers.

Authors:  A I Seldén; N P Berg; E A Lundgren; G Hillerdal; N G Wik; C G Ohlson; L S Bodin
Journal:  Occup Environ Med       Date:  2001-10       Impact factor: 4.402

4.  Cancer incidence among Minnesota taconite mining industry workers.

Authors:  Elizabeth M Allen; Bruce H Alexander; Richard F MacLehose; Heather H Nelson; Gurumurthy Ramachandran; Jeffrey H Mandel
Journal:  Ann Epidemiol       Date:  2015-08-29       Impact factor: 3.797

5.  Hydrothermally processed 1D hydroxyapatite: Mechanism of formation and biocompatibility studies.

Authors:  Zoran S Stojanović; Nenad Ignjatović; Victoria Wu; Vojka Žunič; Ljiljana Veselinović; Srečo Škapin; Miroslav Miljković; Vuk Uskoković; Dragan Uskoković
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2016-06-16       Impact factor: 7.328

6.  Enhanced morphological transformation of human lung epithelial cells by continuous exposure to cellulose nanocrystals.

Authors:  E R Kisin; N Yanamala; D Rodin; A Menas; M Farcas; M Russo; S Guppi; T O Khaliullin; I Iavicoli; M Harper; A Star; V E Kagan; A A Shvedova
Journal:  Chemosphere       Date:  2020-02-13       Impact factor: 7.086

Review 7.  Morphological and chemical mechanisms of elongated mineral particle toxicities.

Authors:  Ann E Aust; Philip M Cook; Ronald F Dodson
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2011       Impact factor: 6.393

8.  Carving of non-asbestiform tremolite and the risk of lung cancer: a follow-up mortality study in a historical nephrite processing cohort.

Authors:  Hsiao-Yu Yang; Ruei-Hao Shie; Pau-Chung Chen
Journal:  Occup Environ Med       Date:  2013-09-18       Impact factor: 4.402

9.  Frequent homozygous deletion of Cdkn2a/2b in tremolite-induced malignant mesothelioma in rats.

Authors:  Yasumasa Okazaki; Nobuaki Misawa; Shinya Akatsuka; Norihiko Kohyama; Yoshitaka Sekido; Takashi Takahashi; Shinya Toyokuni
Journal:  Cancer Sci       Date:  2020-03-21       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.